Cytokine Levels in Metastatic Renal Cell Carcinoma Patients
Author Information
Author(s): Guida Michele, Casamassima Addolorata, Monticelli Giulia, Quaranta Michele, Colucci Giuseppe
Primary Institution: National Oncology Institute, Bari, Italy
Hypothesis
Determining the levels of cytokines in metastatic renal cell carcinoma (MRCC) could help in understanding tumor growth and evaluating correlations with clinical behaviors.
Conclusion
Higher levels of certain cytokines are associated with poorer survival in metastatic renal cell carcinoma patients.
Supporting Evidence
- Higher levels of CRP were correlated with a poorer survival.
- Higher levels of IL-6 were associated with worse survival.
- Higher levels of IL-8 correlated with poorer survival.
- Higher levels of IL-12 were associated with better survival.
- CRP and IL-12 maintained independent impact on survival in multivariate analysis.
Takeaway
This study looked at the levels of certain proteins in the blood of cancer patients and found that higher levels of some proteins mean the patients might not live as long.
Methodology
The study analyzed cytokine levels in 55 MRCC patients and 144 healthy donors, comparing their levels and correlating them with clinical outcomes.
Potential Biases
Potential biases due to the small sample size and the specific patient population studied.
Limitations
The study had a small sample size and results may not be generalizable.
Participant Demographics
55 patients with metastatic renal cell carcinoma, median age 62, 64% men.
Statistical Information
P-Value
p < 0.001 for CRP correlation with response, p = 0.0295 for IL-6 correlation with survival.
Confidence Interval
95% CI for response rate calculated.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website